Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Piomic

Explore full profile

Develops an innovative medical device for the treatment of hard-to-heal wounds

Zurich, SwitzerlandFounded 2016Biotech & Life Sciences
Valuation $50–100M Last recorded · 2022
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Piomic and the history behind them.

About Piomic

Piomic Medical is a startup specializing in advanced medical devices aimed at promoting the healing of chronic wounds. The company operates primarily in the healthcare sector, focusing on patients with chronic leg and foot ulcers, including those suffering from diabetic foot ulcers. Piomic's flagship product, the One Therapy System, is designed to enhance wound healing when used alongside standard treatments.

Piomic serves a diverse client base, including hospitals, clinics, and healthcare providers who treat patients with chronic wounds. The company operates in the global market, with a particular focus on regions where chronic wounds pose a significant healthcare challenge. Currently, Piomic is conducting clinical trials, such as the MAVERICKS trial, to evaluate the effectiveness of its therapy system in the U.S. and Canada. However, the One Therapy System has not yet received regulatory approval in these countries and is limited to investigational use.

Piomic's business model revolves around the development, certification, and sale of its medical devices. The company generates revenue by selling its One Therapy System to healthcare providers and institutions. Additionally, Piomic is actively seeking investors who align with its vision to expand its impact on global wound care.

The company has recently achieved significant milestones, including receiving MDR (Medical Device Regulation) certificates for its Class IIa and Class Is medical devices. This certification is crucial for ensuring the safety and effectiveness of medical devices in the European market.

Piomic is committed to data privacy and complies with the EU General Data Protection Regulation (GDPR) and Swiss data protection laws. The company ensures that personal data is stored, processed, accessed, and transferred securely and does not share personally identifiable information with third parties without explicit consent.

In summary, Piomic Medical is a forward-thinking company dedicated to improving chronic wound care through innovative medical devices, serving healthcare providers globally, and adhering to stringent data privacy standards.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Zurich, Switzerland
Sector
Biotech & Life Sciences

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Commission

Series A4 investors entered at this stage

  • Swiss Diabetes Venture Fund
  • Nest Collective Foundation
  • Verve Ventures
  • ZKB - Zürcher Kantonalbank
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇭 Switzerland86.7%
🇺🇸 United States6.7%
🇳🇿 New Zealand6.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Piomic on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Piomic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.